NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
08/08/2023
Voltar para busca
Dado oficial do USPTO
AB CHECK
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
55
Atualização mais recente
08/08/2023
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
42
Data de depósito
10/08/2018
Data de registro
08/08/2023
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
08/08/2023
Última transação
08/08/2023
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
27/09/2021
Primeiro uso no comércio
27/09/2021
Código do desenho
3
Tipo de titular
16
Localização do titular
Plzen, CZ
Examinador
AVENT, TEAGUE
Unidade examinadora
N70
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of letters "AB" and "CHECK" separated by an array of circles.
Titulares e representantes
Titulares
A. S. (pessoa física)
Representantes
Karen L. Elbing CLARK+ELBING LLP
Classificação técnica
Classes Nice
Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 42
Scientific and technological services and research projects for the preparation of peptide and antibody librarieschemical analysis; scientific and technological services and research projects for the identification and characterisation of binding moleculesin the field of antibody discoveryantibody research and antibody optimization in the nature of working on and evaluation of chemical analyses; scientific and technological services and research projects for the preparationidentification and characterisation of peptides and antibodiesmedical research in the field of antibody discoveryantibody research and antibody optimization; scientific and technological services and research projects for the preparation and identification of recombinant antibodiessingle-chain antibodiesdiabodiestandabsflexibodiestriabodiestetrabodiesbivalent antibodiesmultivalent antibodieswhole immunoglobulinsantibody fragmentsin particular Fab and scFv fragmentsof nucleic acid sequences coding for these moleculesin the field of antibody discoveryantibody research and antibody optimizationscientific research in the field of antibodies; scientific and technological services and research projects in relation to antibody discoverymedical research in the field of antibody research and drug design; scientific and technological services and research projects in relation to screening of naturalengineered and immunized librariesmedical research in the field of antibody discovery for scientific research services; scientific and technological services and research projects in relation to screening of antibody librariesin the field of antibody discovery for scientific research services; scientific and technological services and research projects in relation to phage displayphage panning and yeast display vectorsin the field of antibody discovery in the nature of chemical analysis; scientific and technological services and research projects in relation to next-generation yeast display and antibody selection processin the field of antibody discovery in the nature of chemical analysis; scientific and technological services and research projects in relation to the upstream enrichment of target-specific candidates and batch cloning into yeast-display vectors in the nature of research and development services in the field of antibodies; scientific and technological services in relation to drug discovery by high throughput screen and antibody delivery for therapeutic applicationscientific research in the field of antibody research and drug design; scientific and technological services and research projects in relation to batch-cloning and screening of naturalengineered and immunized librariesscientific research in the field of antibodies and antibody optimization; scientific and technological services and research projects in relation to batch-cloning and screening of antibody librariesscientific research in the field of antibodies and antibody optimization; scientific and technological services and research projects in relation to antibody development strategiesscientific research in the field of antibody research and antibody optimization; scientific and technological services and research projects in relation to the optimizationmaturation and humanization of antibody drug candidatesin the field of antibody research and drug design; scientific and technological services and research projects in relation to multi-factor antibody optimizationscientific research in the field of antibody research and drug design; scientific and technological services and research projects in relation to the optimization of antibody binding affinityantibody stabilityspecies cross-reactivityspecificitydevelopabilityproducibilityhuman propertiesscientific research in the field of antibody research and antibody optimization; scientific and technological services and research projects in relation to human and non-human lead antibody technologyscientific research in the field of antibody research and antibody optimization
Publicações
Histórico de despachos e eventos da marca no USPTO.
55 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
08/08/2023
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
06/07/2023
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
05/07/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
09/06/2023
SUPC
STATEMENT OF USE PROCESSING COMPLETE
08/06/2023
EX5G
SOU EXTENSION 5 GRANTED
08/06/2023
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
30/05/2023
EXT5
SOU EXTENSION 5 FILED
24/05/2023
IUAF
USE AMENDMENT FILED
24/05/2023
EEXT
SOU TEAS EXTENSION RECEIVED
24/05/2023
EISU
TEAS STATEMENT OF USE RECEIVED
24/05/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
01/11/2022
EX4G
SOU EXTENSION 4 GRANTED
28/10/2022
EXT4
SOU EXTENSION 4 FILED
28/10/2022
EEXT
SOU TEAS EXTENSION RECEIVED
28/10/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
19/05/2022
EX3G
SOU EXTENSION 3 GRANTED
17/05/2022
EXT3
SOU EXTENSION 3 FILED
17/05/2022
EEXT
SOU TEAS EXTENSION RECEIVED
17/05/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
28/10/2021
EX2G
SOU EXTENSION 2 GRANTED
26/10/2021
EXT2
SOU EXTENSION 2 FILED
26/10/2021
EEXT
SOU TEAS EXTENSION RECEIVED
26/10/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
22/04/2021
EX1G
SOU EXTENSION 1 GRANTED
20/04/2021
EXT1
SOU EXTENSION 1 FILED
20/04/2021
EEXT
SOU TEAS EXTENSION RECEIVED
20/04/2021
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
24/11/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
29/09/2020
PUBO
PUBLISHED FOR OPPOSITION
29/09/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/09/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
26/08/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
25/06/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
25/06/2020
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
25/06/2020
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
19/04/2020
GNFR
FINAL REFUSAL E-MAILED
19/04/2020
CNFR
FINAL REFUSAL WRITTEN
19/04/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
16/01/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
15/01/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
15/01/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
17/07/2019
GNRT
NON-FINAL ACTION E-MAILED
17/07/2019
CNRT
NON-FINAL ACTION WRITTEN
17/07/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
13/06/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
13/06/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
13/06/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/01/2019
GNRT
NON-FINAL ACTION E-MAILED
02/01/2019
CNRT
NON-FINAL ACTION WRITTEN
02/01/2019
DOCK
ASSIGNED TO EXAMINER
28/11/2018
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
21/08/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
18/08/2018
NWAP
NEW APPLICATION ENTERED
14/08/2018
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace AB CHECK ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.